NeuroPace, Inc.

NasdaqGM NPCE

NeuroPace, Inc. Share Price on January 14, 2025: USD 11.84

NeuroPace, Inc. Share Price is USD 11.84 on January 14, 2025, a -1.17% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

NeuroPace, Inc. 52-week high Share Price is USD 17.50 on February 20, 2024, which is 47.80% above the current Share Price.
NeuroPace, Inc. 52-week low Share Price is USD 5.90 on October 23, 2024, which is -50.17% below the current Share Price.
NeuroPace, Inc. average Share Price for the last 52 weeks is USD 10.05.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqGM: NPCE

NeuroPace, Inc.

CEO	Mr. Joel D. Becker
IPO Date	April 22, 2021
Location	United States
Headquarters	455 North Bernardo Avenue
Employees	184
Sector	Health Care
Industries Pharmaceuticals Telehealth Virtual Reality (VR)

Description

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Key trends

Past 5 years